Molecular Patterns of Resistance Among Helicobacter pylori Strains in South-Western Poland
Open Access
- 18 December 2018
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 9, 3154
Abstract
Treatment failure of Helicobacter pylori infection is caused mainly by progressive antibiotic resistance among H. pylori strains. In Poland, the prevalence of H. pylori strains resistant to metronidazole is higher than in other developed countries, reaching almost 50%, and resistance to clarithromycin is as high as 30% and is still increasing, contributing to the failure of first-line therapy in approximately 70% of patients. Moreover, the introduction of levofloxacin to eradication therapy of H. pylori infection quickly led to the emergence of resistant strains. Therefore, a necessary approach in microbiological diagnostics of H. pylori infection should be determination of susceptibility of H. pylori strains before the eradication treatment. Aim: In this study was to evaluate the molecular mechanisms of resistance among 170 H. pylori strains to clarithromycin, involving mutations in the 23S rRNA gene (A2143G, A2142G, A2143G) and to levofloxacin, involving mutations of gyrA and gyrB. Analysis was performed by using polymerase chain reaction and classical sequencing of DNA fragments. Results: Among examined strains, 26% were fully sensitive and 74% were resistant to at least one of the tested antibiotics. The overall resistance rate to metronidazole was as high as 56%, whereas to clarithromycin 46%, respectively. Resistance to LEV occurred among 6% of strains. All tested strains were susceptible to AMC and TET. The A2143G point mutation was found in 72% of clarithromycin-resistant strains. The most common mutation, present in 40% of H. pylori strains resistant to levofloxacin, was a change at position 91 of gyrA. Conclusion: The increasing number of point mutations in the 23S rRNA gene leads to an increase in the rates of antimicrobial resistance. Presence of the GCG allele at position 122 of the gyrA gene may cause an eightfold increase in risk of development of resistance to levofloxacin.Keywords
Funding Information
- Ministerstwo Nauki i Szkolnictwa Wyższego (No. PBmn146/P01/2007/32, Poland)
This publication has 34 references indexed in Scilit:
- Primary antibiotic resistance and associated mechanisms in Helicobacter pylori isolates from Senegalese patientsAnnals of Clinical Microbiology and Antimicrobials, 2013
- Recent Insights into Antibiotic Resistance inHelicobacter pyloriEradicationGastroenterology Research and Practice, 2012
- Management of Helicobacter pylori infection—the Maastricht IV/ Florence Consensus ReportGut, 2012
- Fluoroquinolone Resistance in Helicobacter pylori: Role of Mutations at Position 87 and 91 of GyrA on the Level of Resistance and Identification of a Resistance Conferring Mutation in GyrBHelicobacter, 2012
- Distribution of Spontaneous gyrA Mutations in 97 Fluoroquinolone-Resistant Helicobacter pylori Isolates Collected in FranceAntimicrobial Agents and Chemotherapy, 2012
- Evidence‐based Guidelines From ESPGHAN and NASPGHAN for Helicobacter pylori Infection in ChildrenJournal of Pediatric Gastroenterology and Nutrition, 2011
- Evaluation of a New Test, GenoType HelicoDR, for Molecular Detection of Antibiotic Resistance inHelicobacter pyloriJournal of Clinical Microbiology, 2009
- Outer Membrane Protein Expression Profile in Helicobacter pylori Clinical IsolatesInfection and Immunity, 2009
- Primary Levofloxacin Resistance and gyrA/B Mutations Among Helicobacter pylori in JapanHelicobacter, 2006
- H pylori antibiotic resistance: prevalence, importance, and advances in testingGut, 2004